Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients.
Saved in:
| Title: | Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients. |
|---|---|
| Authors: | Doi, T1, Takiuchi, H2, Ohtsu, A1, Fuse, N1, Goto, M2, Yoshida, M2, Dote, N3, Kuze, Y3, Jinno, F3, Fujimoto, M4, Takubo, T5, Nakayama, N5, Tsutsumi, R6 |
| Source: | British Journal of Cancer. 2/14/2012, Vol. 106 Issue 4, p666-672. 7p. 4 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 71719389 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Doi%2C+T%22">Doi, T</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Takiuchi%2C+H%22">Takiuchi, H</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Ohtsu%2C+A%22">Ohtsu, A</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Fuse%2C+N%22">Fuse, N</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Goto%2C+M%22">Goto, M</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Yoshida%2C+M%22">Yoshida, M</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Dote%2C+N%22">Dote, N</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Kuze%2C+Y%22">Kuze, Y</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Jinno%2C+F%22">Jinno, F</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Fujimoto%2C+M%22">Fujimoto, M</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Takubo%2C+T%22">Takubo, T</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Nakayama%2C+N%22">Nakayama, N</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Tsutsumi%2C+R%22">Tsutsumi, R</searchLink><relatesTo>6</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Cancer%22">British Journal of Cancer</searchLink>. 2/14/2012, Vol. 106 Issue 4, p666-672. 7p. 4 Charts, 2 Graphs. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=71719389 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/bjc.2011.590 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 666 Titles: – TitleFull: Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Doi, T – PersonEntity: Name: NameFull: Takiuchi, H – PersonEntity: Name: NameFull: Ohtsu, A – PersonEntity: Name: NameFull: Fuse, N – PersonEntity: Name: NameFull: Goto, M – PersonEntity: Name: NameFull: Yoshida, M – PersonEntity: Name: NameFull: Dote, N – PersonEntity: Name: NameFull: Kuze, Y – PersonEntity: Name: NameFull: Jinno, F – PersonEntity: Name: NameFull: Fujimoto, M – PersonEntity: Name: NameFull: Takubo, T – PersonEntity: Name: NameFull: Nakayama, N – PersonEntity: Name: NameFull: Tsutsumi, R IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 02 Text: 2/14/2012 Type: published Y: 2012 Identifiers: – Type: issn-print Value: 00070920 Numbering: – Type: volume Value: 106 – Type: issue Value: 4 Titles: – TitleFull: British Journal of Cancer Type: main |
| ResultId | 1 |
